A shadow market for unapproved slimming medications is propelled by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Drug Gaining Popularity Online
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to message these profiles directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Express Concerns
However, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.
Some professionals stated the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Removal
Based on the social media company, the service has removed problematic content and banned related keywords and query recommendations. The company stated it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Online Marketplace Operations
Investigations also found communities with up to 9,000 members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, filled with photos of weight loss, positive reviews and detailed instructions for mixing or administering at home.
After moments of joining one community, a seller posted WhatsApp details, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Details and Pricing
Inside these groups, posts show dark colored parcels with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram said it regularly moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they can’t verify. Although the research behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has already encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational product not yet approved … may expose users to possibly significant health risks”.